Search Results

Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.

• Authors : Rudenko L; Department of Virology, Institute of Experimental Medicine, 12 Acad. Pavlov Street, Saint Petersburg 197376, Russia. Electronic address: .; Yeolekar L

Subjects: Technology Transfer* ; Vaccination*; Influenza A virus/Influenza A virus/Influenza A virus/*immunology

• Source: Vaccine [Vaccine] 2016 Oct 26; Vol. 34 (45), pp. 5436-5441. Date of Electronic Publication: 2016 Sep 01.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Agricola

Record details

Agricola

Record details

Agricola

Record details

Agricola

Record details

Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant.

• Authors : Stavaru C; a Cantacuzino National Research Institute , Bucharest , Romania.; Onu A

Subjects: Adjuvants, Immunologic* ; Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/immunology ; Technology Transfer*

• Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2016 Apr 02; Vol. 12 (4), pp. 1009-26. Date of Electronic Publication: 2015 Nov 30.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process.

• Authors : Buckland B; Protein Sciences Corporation, 1000 Research Parkway, Meriden, CT 06450, USA; Department of Biochemical Engineering, University College London, Torrington Place, London WC1E 7JE, UK. Electronic address: .

Subjects: Technology Transfer*; Hemagglutinin Glycoproteins, Influenza Virus/Hemagglutinin Glycoproteins, Influenza Virus/Hemagglutinin Glycoproteins, Influenza Virus/*biosynthesis ; Influenza Vaccines/Influenza Vaccines/Influenza Vaccines/*chemistry

• Source: Vaccine [Vaccine] 2014 Sep 22; Vol. 32 (42), pp. 5496-502. Date of Electronic Publication: 2014 Aug 12.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Dual use research. Australian researchers rattled by export control law.

• Authors : Dayton L

Subjects: Technology Transfer*; Research/Research/Research/*legislation & jurisprudence ; Research Personnel/Research Personnel/Research Personnel/*legislation & jurisprudence

• Source: Science (New York, N.Y.) [Science] 2013 Mar 15; Vol. 339 (6125), pp. 1263.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium:

Record details

Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.

• Authors : Rudenko L; Institute of Experimental Medicine, Department of Virology, St Petersburg, Russia.; van den Bosch H

Subjects: Technology Transfer*; Influenza A Virus, H1N1 Subtype/Influenza A Virus, H1N1 Subtype/Influenza A Virus, H1N1 Subtype/*immunology ; Influenza Vaccines/Influenza Vaccines/Influenza Vaccines/*immunology

• Source: Vaccine [Vaccine] 2011 Jul 01; Vol. 29 Suppl 1, pp. A40-4.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print Cited Medium: Internet ISSN: 1873-2518

Record details

An international technology platform for influenza vaccines

• Authors : Hendriks, Jan¹ ; Holleman, Marit²; de Boer, Otto²

Subjects: *INFLUENZA vaccines; *VIRAL vaccines; *INFLUENZA A virus

• Source: Vaccine. Jul2011 Supplement 1, Vol. 29, pA8-A11. 0p.

Record details